Table: Hisamitsu - 9-MTH group results
Jan 12 (Reuters)-
Hisamitsu Pharmaceutical Co Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Nov 30, 2017 Nov 30, 2016 Feb 28, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 109.55 109.73 147.00
(-0.2 pct) (-10.3 pct) (+0.7 pct)
Operating 20.69 22.00 24.10
(-5.9 pct) (-5.7 pct) (-8.4 pct)
Recurring 22.04 22.89 25.60
(-3.7 pct) (-2.5 pct) (-9.2 pct)
Net 15.84 18.34 18.50
(-13.6 pct) (+19.7 pct) (-9.3 pct)
EPS 189.33 yen 216.23 yen 221.12 yen
EPS Diluted 189.19 yen 216.12 yen
Ann Div 81.50 yen 82.00 yen
-Q2 div 41.00 yen 40.50 yen
-Q4 div 41.00 yen 41.00 yen
NOTE - Hisamitsu Pharmaceutical Co Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO